RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor, ERG26, and is an effective and selective target for tumor angiogenesis and vascular disruption27. Here, RHOJ is linked to neoplasm.